Stay updated on Nivolumab After SIRT for HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.

Latest updates to the Nivolumab After SIRT for HCC Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a line stating 'No longer looking for participants,' indicating the study's enrollment status, and adds help sections (How to Read a Study Record, Common Questions, How to Join a Study). A formatting tweak to the Intervention/Treatment heading and an update to the Revision: v3.6.0 are also present to reflect the latest page state.SummaryDifference0.4%

- Check12 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.5.4 to v3.5.5, signaling a minor backend update to the page. This change does not alter study content or details.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3. This reflects a site-wide interface update rather than a change to the study information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s footer/site revision indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or release change without modifying the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded Hepatocellular carcinoma to the site taxonomy and introduced a new Resources entry for the Genetic and Rare Diseases Information Center. Updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Nivolumab After SIRT for HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.